Indeed, FGFR3 mutants with reduced capacity for PLCγ activation strongly attenuated, but not abolished, transformative capacity in Ba/F3 cells and in a bone marrow murine leukemia transplant model, underling the importance of PLCγ for oncogenesis downstream of FGFR3 [216]. The gene discussed is FGFR3; the disease is leukemia.